Published in Pain and Central Nervous System Week, January 28th, 2008
"In this study, we examined the effects of the C5aR blockade on synovial inflammation in RA patients. We performed a double-blind, placebo-controlled study using an orally administered C5aR-antagonist. Twenty-one patients with active RA were randomized 2:1 to treatment with a C5aR-antagonist AcF-...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week